B

BioVex

100 employees

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

1999

Funding rounds raised

Total raised

$40M

from 19 investors over 19 rounds

B

BioVex raised $40M on March 30, 2009

Investors: Sectoral Asset Management, Triathlon Medical Ventures, Ventech, MVM Partners, Omnes, Ysios Capital and -

B

BioVex raised $35M on November 16, 2007

Investors: -, Oxford Finance LLC, ABN AMRO Energy Transition Fund, Avalon Venture and Triathlon Medical Ventures

B

BioVex raised $28M on October 6, 2003

Investors: Temasek, Proven Vct Plc, CLSA, LDC, ABN AMRO Energy Transition Fund and Avalon Venture

B

BioVex raised $4.9M on February 1, 1999

Investors: 2015 Excalibur Group. Reserved

FAQ